Hims & Hers Health announced the acquisition of Livewell, a Canadian digital‑health platform focused on weight‑loss care, marking the company’s first entry into the Canadian market.
The deal brings Livewell’s established network and local expertise, enabling Hims & Hers to launch its subscription‑based weight‑loss program in Canada. The acquisition is part of a broader strategy to broaden its addressable market through geographic expansion and specialty growth.
Austin Kouri will serve as General Manager for Canadian operations and Sandy Van will be Chief Medical Officer for Canada, ensuring local leadership and clinical oversight.
The acquisition aligns with the anticipated availability of generic semaglutide in Canada, which is expected to lower costs and increase access to obesity treatments. Nearly two‑thirds of Canadian adults are overweight or obese, creating a sizable market for Hims & Hers’ personalized care model.
While the financial terms of the transaction were not disclosed, the move complements Hims & Hers’ recent financial performance, which saw Q3 2025 revenue rise 49% YoY to $599 million, gross margin fall to 74% from 79% in Q3 2024, and adjusted EBITDA climb to $78.4 million from $51.1 million. The company continues to invest in growth while managing margin compression.
CEO Andrew Dudum emphasized that the Canadian expansion is a direct response to a critical public health need and a step toward democratizing access to personalized, high‑quality care. He added that the company is building a platform that gets more personal, more proactive, and resonates with more people as it scales.
The acquisition also fits into Hims & Hers’ broader portfolio of strategic initiatives, including the planned acquisition of YourBio Health for blood‑sampling technology and a new $250 million share repurchase program, underscoring the company’s commitment to growth and shareholder value.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.